Analysts have lowered their price target for ProAssurance from $25.00 to $22.67. This change reflects revised expectations around the company’s fair value based on recent financial performance.
What's in the News
- Between April 1, 2025 and June 30, 2025, ProAssurance did not repurchase any shares during its ongoing buyback tranche (Key Developments).
- As of June 30, 2025, the company has completed the repurchase of 12,758,534 shares. This represents 22.5% of shares for a total of $490.42 million under the buyback program initiated on February 24, 2011 (Key Developments).
Valuation Changes
- Fair Value Estimate has decreased from $25.00 to $22.67, reflecting a lower consensus on ProAssurance’s intrinsic worth.
- Discount Rate remains unchanged at 6.78%, indicating no adjustment in the risk profile applied to future cash flows.
- Revenue Growth projection is essentially stable, moving marginally from -1.80% to -1.80%.
- Net Profit Margin expectation is unchanged at approximately 6.69%, suggesting consistent profitability forecasts.
- Future P/E Ratio has declined from 22.13x to 20.06x, indicating a reduced growth premium assigned by analysts.
Have other thoughts on ProAssurance?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.